Unique Ingredient Identifier IY9XDZ35W2 is listed as a unspecified ingredient
| NCIT | C2831 |
| RXCUI | 4850 |
UNII IY9XDZ35W2 DEXTROSE, UNSPECIFIED FORM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,CNBLK INTRATHECAL | INJECTION | 7.5 % |
| IM - IV | INJECTION | 5 % |
| IM - IV - SC | INJECTION | NA |
| INTERSTITIAL | INJECTION | NA |
| INTRACAVITARY | INJECTION | NA |
| INTRAMUSCULAR | INJECTION | 4.4 %W/V |
| INTRAPERITONEAL | INJECTION | NA |
| INTRAPLEURAL | INJECTION | NA |
| INTRASPINAL | INJECTION | 5 % |
| INTRAVENOUS | INJECTABLE | 5 % |
| INTRAVENOUS | INJECTION | NA |
| INTRAVENOUS | INJECTION, SOLUTION | 5 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 5.02 % |
| INTRAVENOUS | SOLUTION | 0.05 % |
| INTRAVENOUS | SOLUTION, INJECTION | 5 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 5 % |
| NASAL | SPRAY | 5300 UG/SPRAY |
| NASAL | SPRAY | 5 MG/SPR |
| NASAL | SPRAY, METERED | 5 % |
| ORAL | CAPSULE, DELAYED ACTION | 1.1 MG |
| ORAL | CONCENTRATE | 40 MG/ML |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 2813 MG |
| ORAL | LIQUID | 160 MG/4ML |
| ORAL | PASTILLE | 826 MG |
| ORAL | PELLET | 2813 MG |
| ORAL | POWDER, FOR SOLUTION | NA |
| ORAL | SOLUTION | 2489 MG/5ML |
| ORAL | SOLUTION, ELIXIR | NA |
| ORAL | SUSPENSION | 500 MG/5ML |
| ORAL | SYRUP | 1350 MG/5ML |
| ORAL | TABLET | 183.66 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 398 MG |
| ORAL | TABLET, EXTENDED RELEASE | 103.95 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 1.2 MG |
| ORAL | TABLET, SUSTAINED ACTION | 2 MG |
| ORAL | TABLET, UNCOATED, TROCHE | 903.5 MG |
| SPINAL | INJECTION | 7.5 % |
| SUBLINGUAL | TABLET | 115.78 MG |